Methods: Four millimeter diameter, full thickness calvarial defects were made in female C57/BL and FSTL3 knockout (FSTL3 -/-) mice. Subsequently, tissue engineered scaffolds containing bone marrow derived mesenchymal stem cells (BMSCs) were placed in the defects and the incisions closed. Mice (n=5/gr) were either subjected to: (i) no treatment; (ii) gentle treadmill walking (TW; 7m/min for 45min/day); (iii) subcutaneous injection of BMP-2 (0.5 µg/mouse); or (iv) injection with FSTL3 (300 ng/mouse). The calvaria were harvested 6 or 12 weeks later and examined for bone formation by µCT, histology, and immunohistochemistry.
Results: Bone formation to some extent was observed in all defects implanted with BMSC-containing scaffolds. However, TW induced significantly greater (4 ± 0.6 fold) vascularized bone formation. A 3.2 ± 0.7 fold increase in bone formation was observed in mice injected with FSTL3; likewise, a similar increase of bone formation (2.9 ± 0.6 fold) was observed in mice injected with BMP-2. Histologically, the bone formation in mice subjected to TW demonstrated a well-integrated bone that was homogeneously connected with the calvarial bone. However, bone integration in response to FSTL3 or BMP-2 was incomplete 12 wks following implantations. Importantly, TW failed to induce bone formation in Fstl3-/- mice.
Conclusions: Our data suggest that biomechanical stimulation is a potent inducer of bone formation, even in bones that are not directly stimulated. Patients could possibly benefit from prescribed exercise programs. Furthermore, the identification of FSTL3 as an inducer of bone formation provides a novel paradigm for future therapies aimed at augmenting bone formation, especially in large or difficult to heal bone defects.